Open access · CC-BY
via OpenAlex
Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma
Wenhan Cai, Miao Jing, Jiaxin Wen, Hua Guo, Zhiqiang Xue
Frontiers in Genetics · 2022 · ▲ 5 citations
Abstract
This study focused on the epigenetic alterations of DNA methylation and miRNAs for lung adenocarcinoma (LUAD) diagnosis and treatment using bioinformatics analyses. DNA methylation data and mRNA and miRNA expression microarray data were obtained from The Cancer Genome Atlas (TCGA) database. The differentially methylated genes (DMGs), differentially expressed genes (DEGs), and differentially expressed miRNAs were analyzed by using the limma package. The DAVID database performed GO and KEGG pathway enrichment analyses. Using STRING and Cytoscape, we constructed the protein–protein interaction (PPI) network and achieved visualization. The online analysis tool CMap was used to identify potential small-molecule drugs for LUAD. In LUAD, 607 high miRNA-targeting downregulated genes and 925 low miRNA-targeting upregulated genes, as well as 284 hypermethylated low-expression genes and 315 hypomethylated high-expression genes, were obtained. They were mainly enriched in terms of pathways in cancer, neuroactive ligand–receptor interaction, cAMP signaling pathway, and cytosolic DNA-sensing pathway. In addition, 40 upregulated and 84 downregulated genes were regulated by both aberrant alternations of DNA methylation and miRNAs. Five small-molecule drugs were identified as a potential treatment for LUAD, and five hub genes (SLC2A1,PAX6,LEP,KLF4, andFGF10) were found in PPI, and two of them (SLC2A1andKLF4) may be related to the prognosis of LUAD. In summary, our study identified a series of differentially expressed genes associated with epigenetic alterations of DNA methylation and miRNA in LUAD. Five small-molecule drugs and five hub genes may be promising drugs and targets for LUAD treatment.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fgene.2022.817552
- Canonical
- link ↗
- Fetched
- 2026-10-04 MST
Cite this
APA
Cai, W., Jing, M., Wen, J., Guo, H., & Xue, Z. (2022). Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma. <em>Frontiers in Genetics</em>. https://doi.org/10.3389/fgene.2022.817552
Vancouver
Cai W, Jing M, Wen J, Guo H, Xue Z. Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma. Frontiers in Genetics. 2022. doi:10.3389/fgene.2022.817552.
BibTeX
@article{wenhan2022Epigen,
title = {Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma},
author = {Wenhan Cai and Miao Jing and Jiaxin Wen and Hua Guo and Zhiqiang Xue},
journal = {Frontiers in Genetics},
year = {2022},
doi = {10.3389/fgene.2022.817552},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Cellular and Molecular Medicine 2020
Open access · CC-BY
Epigenetic alternations of microRNAs and DNA methylation contribute to gestational diabetes mellitus
BMC Genomics 2025
Open access · CC-BY
Unravelling the transcriptomic symphony of muscle ageing: key pathways and hub genes altered by ageing and caloric restriction in rat muscle revealed by RNA sequencing
bioRxiv (Cold Spring Harbor Laboratory) 2024
Preprint · CC-BY
Unravelling the Transcriptomic Symphony of Sarcopenia: Key Pathways and Hub Genes Altered by Muscle Ageing and Caloric Restriction Revealed by RNA Sequencing
Jurnal Locus Penelitian dan Pengabdian 2026
Open access · CC-BY
Transcriptomic Identification of Mitochondrial Dysfunction Signatures Associated with Ischemic Stroke
Frontiers in Cell and Developmental Biology 2021
Open access · CC-BY
Characterization of DNA Methylation and Screening of Epigenetic Markers in Polycystic Ovary Syndrome
Molecular Medicine Reports 2017
Open access · OA